Peng Wang Appointed WuXi PharmaTech VP of Discovery Biology

June 11, 2008
BioPharm International Editors

WuXi PharmaTech (Shanghai, China) has appointed Peng Wang, PhD as vice president of discovery biology.

WuXi PharmaTech (Shanghai, China) has appointed Peng Wang, PhD as vice president of discovery biology. Prior to joining WuXi PharmaTech, Wang was a research fellow at the Schering-Plough Research Institute, where he worked for 18 years. He has extensive experience in discovery biology, including target validation research, assay development, screening, in vitro, and in vivo biological and pharmacological studies, and biomarker research. In his new role, Wang will oversee the WuXi PharmaTech’s portfolio of discovery biology service offerings.

WuXi release

Related Content:

News